The effect of green tea mouthwash on oral inflammination and oral health related quality of life in patients with obstructive pulmonary disease using inhaled corticosterois

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250323065143N1

Enrollment

Registered

2025-07-07

Start date

2025-07-21

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary diseases. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention group:oral rinsing is performed using a 5% water-based green tea extract solution. The mouthwash is used three times daily over a three-week period..

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: no clinical signs of inflammation or obvious sores in the mouth absence of autoimmune disease or any disease that requires the use of coticosteroids starting inhaled corticosteroids at the same time as starting the plan

Exclusion criteria

Exclusion criteria: problems with mental health conditions unwillingness to continue research not rinsing your mouth regularly

Design outcomes

Primary

Measure	Time frame
Oral health-related quality of life in COPD patients using inhaled corticosteroids. Timepoint: befor start of study, 1week later, and end of study. Method of measurement: Oral Health-Related Quality of Life in COPD Patients Using Inhaled Corticosteroids: Based on the OHIP-14 Questionnaire.;Oral inflammation level. Timepoint: befor start of study, 1week later, and end of study. Method of measurement: beck oral assessment score tool.	—

Measure

Time frame

Oral health-related quality of life in COPD patients using inhaled corticosteroids. Timepoint: befor start of study, 1week later, and end of study. Method of measurement: Oral Health-Related Quality of Life in COPD Patients Using Inhaled Corticosteroids: Based on the OHIP-14 Questionnaire.;Oral inflammation level. Timepoint: befor start of study, 1week later, and end of study. Method of measurement: beck oral assessment score tool.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahar Zakeri Nasab

Mashhad University of Medical Sciences

zakerinasabb4012@mums.ac.ir+98 51 3806 7165

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026